CIK 0001080014 · Large accelerated filer
Innoviva, Inc.
Sign in to watch- Ticker
- INVA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 943265960
- Phone
- 6502389600
- Business address
- 1350 OLD BAYSHORE HIGHWAY, SUITE 400, BURLINGAME, CA, 94010
- Former names
- THERAVANCE INC, ADVANCED MEDICINE INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-05-20 | GLAXOSMITHKLINE PLC 10% owner | Sale | −32,005,260 | $12.25 | $392.1M | 0 |
| 2015-08-07 | GLAXOSMITHKLINE PLC 10% owner | Purchase | +245,828 | $3,485,841.04 | $856.9B | 32,005,260 |
| 2015-05-11 | GLAXOSMITHKLINE PLC 10% owner | Purchase | +85,579 | $1,369,264.00 | $117.2B | 31,759,432 |
| 2015-03-02 | GLAXOSMITHKLINE PLC 10% owner | Purchase | +92,674 | $1,673,692.44 | $155.1B | 31,673,853 |
| 2014-11-04 | GLAXOSMITHKLINE PLC 10% owner | Purchase | +832,456 | $12,786,524.16 | $10644.2B | 31,581,179 |
| 2014-08-11 | GLAXOSMITHKLINE PLC 10% owner | Purchase | +172,651 | $3,912,271.66 | $675.5B | 30,748,723 |
| 2014-05-09 | GLAXOSMITHKLINE PLC 10% owner | Purchase | +317,770 | $8,544,835.30 | $2715.3B | 30,576,072 |
| 2014-02-11 | GLAXOSMITHKLINE PLC 10% owner | Purchase | +342,229 | $12,850,698.95 | $4397.9B | 30,258,302 |
| 2013-10-29 | GLAXOSMITHKLINE PLC 10% owner | Purchase | +130,473 | $4,913,613.18 | $641.1B | 29,916,073 |
| 2013-07-30 | GLAXOSMITHKLINE PLC 10% owner | Purchase | +3,064,407 | $111,850,855.50 | $342756.5B | 29,785,600 |
| 2013-04-30 | GLAXOSMITHKLINE PLC 10% owner | Purchase | +193,563 | $6,699,215.43 | $1296.7B | 26,721,193 |
| 2013-02-15 | GLAXOSMITHKLINE PLC 10% owner | Purchase | +116,527 | $2,567,089.81 | $299.1B | 26,527,630 |
| 2012-11-02 | GLAXOSMITHKLINE PLC 10% owner | Purchase | +280,348 | $6,265,777.80 | $1756.6B | 26,411,103 |
| 2012-08-03 | GLAXOSMITHKLINE PLC 10% owner | Purchase | +316,334 | $28.21 | $8.9M | 26,130,755 |
| 2012-05-16 | GLAXOSMITHKLINE PLC 10% owner | Purchase | +10,000,000 | $21.29 | $212.9M | 25,814,421 |
| 2012-02-14 | GLAXOSMITHKLINE PLC 10% owner | Purchase | +88,468 | $18.12 | $1.6M | 15,814,421 |
| 2011-11-01 | GLAXOSMITHKLINE PLC 10% owner | Purchase | +58,411 | $22.23 | $1.3M | 15,725,953 |
| 2011-08-02 | GLAXOSMITHKLINE PLC 10% owner | Purchase | +102,466 | $19.71 | $2.0M | 15,667,542 |
| 2011-07-21 | GLAXOSMITHKLINE PLC 10% owner | Conversion | +9,401,499 | 15,565,076 | ||
| 2011-07-21 | GLAXOSMITHKLINE PLC 10% owner | Conversion · Class A Common Stock | −9,401,499 | 0 |
Page 1 of 2 · 24 trades